MicroRNAs (miRNAs) play a critical role on biological and cellular processes; the search for functional markers may be of importance for differential diagnosis, prognosis, and development of new therapeutic regimens. In this context, we evaluated the bone marrow miRNA profile of Brazilian children exhibiting T-or B-cell acute lymphoblastic leukemia (T-ALL or B-ALL), using massive parallel sequencing, using the HiSeq 2500 platform (Illumina). The differential expression analysis was conducted considering a leave-one-out approach and FDR ≤ 0.05. Machine learning algorithms were applied to search for the disease subset biomarkers. Target prediction, functional enrichment, and classification of biological categories were also performed. Sixteen miRNAs were differentially expressed between T-and B-ALL, of which 10 (miR-708-5p, miR-497-5p, miR-151a-5p, miR-151b, miR-371b-5p, miR-455-5p, miR-195-5p, miR-1266-5p, miR-574-5p, and miR-425-5p) were downregulated and six (miR450b-5p, miR-450a-5p, miR-542-5p, miR-424-5p, miR-629-5p, and miR-29c-5p) were upregulated in childhood T-ALL. These miRNAs may be used for distinguishing childhood lymphoblastic leukemia subtypes, since it provided the clear separation of patients in these two distinct groups. Six relevant biological pathways were identified according to their role in leukemia, namely, viral carcinogenesis, cell cycle, and B-cell receptor signaling pathways for induced miRNAs and TGF-beta signaling, apoptosis, and NF-kappa B signaling for the repressed miRNAs, of which several miRNA gene targets participate in cell differentiation and hematopoiesis processes. Machine learning analysis pointed out miR-29c-5p expression as the best discriminator between childhood T-and B-ALL, which is involved in calcium signaling, critical for B-cell lymphocyte fate. Further studies are needed to assure the role of the 16 miRNAs and miR-29c-5p on acute lymphoblastic leukemia subtypes and on disease prognosis.
chromosomal translocations, ploidy of blasts, or both. [2] [3] [4] Specific miRNAs have also been identified as potential biomarkers of disease severity and disease prognosis, such as miR-155, whose expression has been associated with complete response in patients with chronic lymphocytic leukemia. 5 Besides the availability of immunological and genetic markers, the search for functional markers may be of importance for differential diagnosis, prognosis, and development of new therapeutic regimen. In this context, the miRNA profile of children exhibiting T-or B-cell acute lymphoblastic leukemia (T-ALL or B-ALL) was determined using massive parallel sequencing, which may disclose previously described and novel sets of miRNAs.
2 | METHODS
| Patients
We studied eight children (aged 4-16 y; seven boys and one girl)
exhibiting T-ALL (one early T-cell precursor-ALL, four pre-T-ALL, one cortical T-ALL, and two mature T-cell) and eight patients 
| Identification and characterization of T-and B-cell leukemia
ALL diagnosis was performed evaluating bone marrow or peripheral blood blasts that were morphologically classified according to the French-American-British cooperative group. 6 Samples were submitted to cell separation using Ficoll-Paque gradient (GE Healthcare, Little
Chalfont, UK), and the isolated mononuclear cell fraction was used for immunophenotyping analysis. T-cell lineage leukemia was con- Patient bone marrow cells were also tested to detect the genetic errors, encompassing the HOX11L2 and SIL/TAL alterations, 8 common in T-cell leukemia, and the t(1;19), t(4;11), t(9;22), and t(12;21) genetic alterations, described for B-lineage leukemia. These genetic alterations were determined according to prior study. Table 1) . The dendrogram and the heatmap shown in Figure 1 display the hierarchical clustering of T-ALL and B-ALL samples, based on the 16 differentially expressed miRNAs. 
Target genes obtained by in silico prediction using the miRWalk and miRTarBase databases were submitted to enrichment analyses of biological pathways. Eighteen significant pathways were associated to genes targeted by overexpressed miRNAs in T-ALL, whereas 93 pathways were shared by targets for overexpressed and underexpressed miRNAs and 13 were unique pathways for underexpressed miRNAs.
The most significant pathways of each analysis are illustrated in This approach revealed that eight out of 210 genes and 27 out of 143 genes were targeted by induced or repressed miRNAs, respectively, in T-ALL. The nonreceptor tyrosine kinase was the major class of proteins modulated by the upregulated miRNAs, and growth factors and the family of tumor necrosis factors were the major actors for repressed miRNAs (Table 2 ).
| Machine learning and miRNA expression validation
The machine learning analysis revealed that, among the 16 differentially expressed miRNAs observed in the study, hsa-miR-29c-5p was the best predictor for leukemia subtypes, exhibiting an accuracy of 95% and a ROC area of 0.953. This miRNA participates in four enriched pathways, namely, calcium signaling pathway, insulin resistance, dopaminergic synapse, and transcriptional misregulation in cancer. miR-29c-5p targeted 19 genes of the calcium signaling pathway, three of them were related to some type of cancer, and from the 17 targeted genes related to the transcriptional misregulation in cancer, nine were previously associated with cancer according to Cancer Gene Census, particularly, with hematological malignancies (multiple myeloma; leukemia). These results are demonstrated in Table 3 .
Given the machine learning results, hsa-miR-29c-5p was selected for expression validation by qRT-PCR. We confirmed miRNA-Seq data and bioinformatic analysis and showed that miR-29c-5p expression is higher in T-ALL than in B-ALL (relative quantification, P = 0.0002, Figure 4A ; comparison between Cts, P = 0.0010, Figure 4B ). We also observed that miRNA expression did not differed between pre-pre-B-and pre-B-ALL (P = 0.6842, Figure 4C ) or between T-ALL subtypes (P = 0.4513, Figure 4D ). We showed no differences between less and more mature subtypes (ETP and pre-T-ALL versus cortical and mature T-ALL, P = 0.6295, Figure 4E ) and also did not observe difference on the hsa-miR-29c-5p expression in bone marrow compared with peripheral blood samples (P = 0.1713, Figure 4F ). These findings confirmed that the miR-29c-5p expression predicts ALL cell lineage, but it is not associated with a specific subtype within the cell lineage, nor maturation stage.
| DISCUSSION
Considering that (1) 
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Tumor necrosis factor ligand superfamily member 14 Tumor necrosis factor family member from chronic lymphocytic leukemia (CLL) patients with high cell counts exhibited higher apoptosis rates than those cells from patients with low cell counts. In our previous study, we observed a correlation between high blood cell counts in T-ALL and increased soluble HLA-G levels, an immunologic factor induced by hypoxia, 28 and high cellular density has been shown to be associated with hypoxic environment. 29, 30 Many genes that present a relevant role in cell differentiation and hemopoiesis are ligands of TGF-beta superfamily or intracellular molecules of NF-κB signaling and seem to be overexpressed in T-ALL, possibly due to its posttranscriptional regulation by miRNAs. TGF-beta and NF-κB signaling pathways have already been reported to be 34 and T-cell leukemia. [35] [36] [37] The genes targeted by upregulated miRNAs in T-ALL are primarily related to viral carcinogenesis, cell cycle, and B-cell receptor. Several lines of evidence support the role of virus infections on the pathogenesis of T-ALL, particularly in association with adult T-cell leukemia. 38, 39 On the other hand, the most known evidence for previous EpsteinBarr virus infection is associated with the childhood B-ALL. 40 Cell cycle pathways are deregulated in both lymphocytic leukemias, but in this study, the more prominent posttranscriptional deregulation 
41-44
Interestingly, among all the differentially expressed miRNAs observed in this study, the most prominent putative biomarker of disease subtype was miR-29c-5p, which was a better discriminator than hsa-miR-708-5p, a reported miRNA with differential expression between childhood T-and B-ALL. 19, 45 Enrichment analysis shows that miR-29c-5p is involved on transcriptional dysregulation in cancer and in pathways related to leukemia development, including T-ALL.
Another important pathway, calcium signaling, may be upregulated in B-ALL due to downregulation of miR-29c-5p expression, which has a critical role in B-cell lymphocyte fate and defective signaling in chronic lymphocytic leukemia signaling. 46 miR-29c-5p was upregulated in T-ALL and does not have a defined role in leukemias; however,
another member of the miR-29 family, miR-29c-3p, is modulated in many hematological malignancies, including acute and chronic leukemias, 47 ,48 and lymphomas. 49, 50 On the other hand, miR-29c-5p has breast cancer, 52 and its downregulation is associated with metastasis and cell proliferation. 51 Besides genetic abnormalities observed in Band T-cell leukemias, distinct posttranscriptional regulation of leukemogenic genes may be present yielding different molecular mechanisms of growth and malignant transformation. Further and larger studies are needed to assure the role of miR-29c-5p on acute lymphoblastic leukemia subtype and to clarify whether its expression is related to a favorable leukemia prognosis, as reported in malignant pleural mesothelioma 53 and gallbladder carcinoma. 51 
| CONCLUSION
We report a set of 16 differentially expressed miRNAs that may distinguish childhood lymphoblastic leukemia subtypes in terms of posttranscriptional functional analysis and validate a novel leukemogenic marker, miR-29c-5p, that discriminates T-ALL from B-ALL.
